Services

Provides expert reports on (non)infringement and/or (in)validity, rebuttals, and specialized opinions
Focuses consulting on polymorphism and solvatomorphism (hydrates and solvates) of active pharmaceutical ingredients (APIs) and topics related to the development of APIs, salt/cocrystal and polymorph selection, and solid-state properties as determined by XRPD, DSC, TGA, DTA, DVS, Raman, IR, UV-Vis, hot stage microscopy, particle sizing techniques, etc.
Provided expert consulting services in a variety of settings, including API development (e.g., Biogen, Sanofi, Novartis, a French pharmaceutical company), specialized training (e.g., Sanofi, UBM-India, Treffen-India), and API patent litigation (US Department of Justice, >15 law firms from USA, Canada, UK, and European Union)
Deposition tested, comfortable in both (in)validity and (non)infringement aspects
Represented both innovator and generic companies
Partnered with reputable analytical and organic synthesis laboratories to confirm/question/ disprove the results of the patent examples and/or test the samples.

Provides expert consulting services on crystallization/precipitation mode selection, process design, size targeting/manipulation, polymorph targeting, troubleshooting, and process optimization
Partnered with a reputable crystallization development laboratory to test/optimize/scale up crystallization procedures and analyze crystalline product

Ranked high among polymorphism experts